DNA Sequencing Market, By Product Type (Instruments, Consumables (Kits, Reagents), and Others), By Platform (Sanger, Next Generation Sequencing, and Others), By Application (Diagnostics, Personalized Medicine, and Others (Biomarkers, Forensics, and Reproductive Health), By End-user (Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

DNA sequencing is a laboratory technique which involves both Sangers and Non-Sangers method of sequencing. DNA sequencing is a procedure in which DNA is extracted, fragmented, and linked to primers and adapters for the amplification reaction (PCR) for library construction. Further, sequencing of the fragmented DNA is performed that provides a massive set of sequence data in short duration. This data is analyzed and interpreted by researchers, clinicians, scientists, and others through clinical, forensic, agricultural, and other applications. For example, DNA sequencing has aided researchers to detect desirable traits, which have led to productive and resilient livestock and crops. Increasing usage and application of DNA sequencing is projected to boost growth of the market.

The cost for installation of sequencing platforms is declining significantly. This is estimated to have a positive impact on the demand for NGS techniques over the forecast period. Improvement in novel products and services by key players is also expected to drive the global DNA sequencing market growth. Further, companies are also focusing to increasing their installation base by providing the NGS services in different countries as well as launching economical sequencing devices for routine medical checkups. For instance, in April 2018, Agilent Technologies signed an agreement to acquire Lasergen, Inc. to improve next-generation sequencing workflow for clinical applications. Whereas, in June 2018, Oxford Gene Technology lengthened its NGS Custom Cancer Panel, SureSeq myPanel, which allowed the investigators to focus on cancer-related genes. Additionally, growth in collaborations & partnerships, rise in technological advancements in DNA sequencing, and increase in genome mapping programs globally are the major factors propelling growth of the target market. Moreover, rise in investment in R&D boosts the demand for DNA sequencing and thereby provides lucrative opportunities for the global market growth. However, ethical & legal limitations and standardization & accuracy concerns associated with DNA sequencing restrain the target market growth.

The DNA sequencing market is segmented based on product type, platform, application, end-user, and region.

On the basis of product type, the global DNA sequencing market is segmented into instruments, consumables (kits, reagents), and others. Based on platform, the global market is classified into sanger, next generation sequencing, and others. On the basis of application, the target market is segmented into diagnostics, personalized medicine, and others (biomarkers, forensics, and reproductive health. Based on end-user, the global market is bifurcated into hospitals and healthcare organizations, academics and research institutions, pharmaceutical and biotechnology companies, and others.

On region the global DNA sequencing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America dominated the key regional market and is expected to expand over the forecast period owing to precision medicine, simultaneous developments of NGS, and companion diagnostics. Strong presence of prominent key players, such as Roche Holding AG, contributes to the introduction of rapid and high throughput sequencing capabilities, thereby driving the global market growth. Moreover, majority of the academic hospitals, research centers, and clinics using NGS services and products are located in U.S. Asia Pacific is also expected to have a significant growth owing to increasing developments by key companies for technological integration of NGS methodologies. For instance, in January 2018, Illumina, Inc. collaborated withKingMed Diagnostics to use Illumina’s NGS technology for hereditary disease and oncology testing.

DNA Sequencing Market, By Product Type:

• Instruments
• Consumables (Kits, Reagents)
• Others

DNA Sequencing Market, By Platform:

• Sanger
• Next Generation Sequencing
• Others

DNA Sequencing Market, By Application:

• Diagnostics
• Personalized Medicine
• Others (Biomarkers, Forensics, and Reproductive Health)

DNA Sequencing Market, By End-user:

• Hospitals and Healthcare Organizations
• Academics and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Others

DNA Sequencing Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa DNA Sequencing Market, By Product Type
    • Middle East & Africa DNA Sequencing Market, By Platform
    • Middle East & Africa DNA Sequencing Market, By Application
    • Middle East & Africa DNA Sequencing Market, By End-user
    • Middle East & Africa DNA Sequencing Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America DNA Sequencing Market, By Product Type
    • Latin America DNA Sequencing Market, By Platform
    • Latin America DNA Sequencing Market, By Application
    • Latin America DNA Sequencing Market, By End-user
    • Latin America DNA Sequencing Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific DNA Sequencing Market, By Product Type
    • Asia Pacific DNA Sequencing Market, By Platform
    • Asia Pacific DNA Sequencing Market, By Application
    • Asia Pacific DNA Sequencing Market, By End-user
    • Asia Pacific DNA Sequencing Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific                                                                    
  • Europe
    • Europe DNA Sequencing Market, By Product Type
    • Europe DNA Sequencing Market, By Platform
    • Europe DNA Sequencing Market, By Application
    • Europe DNA Sequencing Market, By End-user
    • Europe DNA Sequencing Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America DNA Sequencing Market, By Product Type
  • North America DNA Sequencing Market, By Platform
  • North America DNA Sequencing Market, By Application
  • North America DNA Sequencing Market, By End-user
  • North America DNA Sequencing Market, By Country
    • U.S.
    • Canada

The key players operating the global DNA sequencing market includes Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Illumina, Inc., Danaher Corporation (Beckman Coulter, Inc.), Merck KGaA, Eurofins Scientific, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in August 2018, Illumina accepted approval for MiSeq Dx Sequencing System from the China National Drug Administration.

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche, Illumina, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• Merck KGaA
• Eurofins Scientific
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific, Inc.

 “*” marked represents similar segmentation in other categories in the respective section